QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
QQQ   294.62 (+1.50%)
AAPL   144.29 (+0.90%)
MSFT   247.81 (+2.10%)
META   148.97 (+1.30%)
GOOGL   98.84 (+1.96%)
AMZN   103.13 (+2.57%)
TSLA   173.22 (+3.94%)
NVDA   195.37 (+1.96%)
NIO   12.07 (+0.42%)
BABA   110.20 (-0.90%)
AMD   75.15 (+3.73%)
T   20.37 (+1.04%)
MU   60.30 (-2.28%)
F   13.51 (+4.81%)
CGC   3.03 (+6.69%)
GE   80.48 (-0.43%)
DIS   108.49 (+0.84%)
AMC   5.35 (+6.79%)
PFE   44.16 (+1.40%)
PYPL   81.49 (+2.32%)
NFLX   353.86 (+0.21%)
NASDAQ:RARE

Ultragenyx Pharmaceutical - RARE SEC Filings & 10K Form

$45.33
+2.35 (+5.47%)
(As of 01/31/2023 05:19 PM ET)
Add
Compare
Today's Range
$43.23
$45.34
50-Day Range
$34.59
$47.44
52-Week Range
$33.36
$85.53
Volume
603,698 shs
Average Volume
688,220 shs
Market Capitalization
$3.18 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$92.00

Recent Ultragenyx Pharmaceutical SEC Filings

DateFilerForm TypeView
01/06/2023
3:19 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/03/2023
3:45 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2022
12:24 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2022
3:11 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2022
3:10 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2022
5:49 PM
Dier Mardi (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/14/2022
11:58 AM
Dier Mardi (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2022
8:39 PM
Dier Mardi (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/15/2022
3:07 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2022
5:36 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2022
3:12 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2022
7:36 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/29/2022
2:48 PM
Sanders Corazon D. (0001796536) (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
12:50 PM
Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
12:51 PM
NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
12:52 PM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
12:53 PM
Ekman Lars (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
12:54 PM
Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
12:48 PM
Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2022
12:48 PM
SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:12 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/22/2022
6:27 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2022
7:06 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2022
3:01 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2022
11:30 AM
Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/22/2022
11:31 AM
Ray Amrit (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2022
7:05 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2022
11:56 AM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2021
5:22 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/02/2021
5:11 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2021
10:56 AM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2021
7:46 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2021
5:22 PM
SULIMAN SHEHNAAZ (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:23 PM
NARACHI MICHAEL (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:24 PM
Fust Matthew K (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:24 PM
Ekman Lars (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:25 PM
Dunsire Deborah (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:26 PM
Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/28/2021
5:27 PM
Ultragenyx Pharmaceutical (Issuer)
WELCH DANIEL G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2021
8:00 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2021
4:55 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2021
8:08 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2021
7:35 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2021
7:46 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2021
7:46 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
5:14 PM
Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:09 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:10 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:11 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:11 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:12 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:13 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
5:13 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
3:46 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2021
10:32 AM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2021
7:07 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2021
4:16 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2021
4:17 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2021
5:03 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2021
11:37 AM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:55 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:38 PM
Dier Mardi (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:39 PM
Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:42 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:43 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:47 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:48 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:36 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
7:37 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2021
1:30 PM
Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2021
7:01 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2021
7:02 PM
Aliski William (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2021
7:03 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
02/03/2021
7:04 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2021
3:28 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2021
7:46 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2021
3:01 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:15 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2021
6:05 PM
Huizenga Theodore Alan (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
8:16 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2021
5:45 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2020
3:15 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2020
3:55 PM
Arcturus Therapeutics Holdings Inc. (Issuer)
Ultragenyx Pharmaceutical (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2020
5:04 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
2:44 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
4:05 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/02/2020
3:05 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2020
4:26 PM
Solid Biosciences Inc. (Issuer)
Ultragenyx Pharmaceutical (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/30/2020
4:28 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/27/2020
3:20 PM
Ultragenyx Pharmaceutical (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/27/2020
3:07 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/26/2020
3:11 PM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2020
7:16 AM
Ultragenyx Pharmaceutical (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2020
6:18 PM
Huang Dennis Karl (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:19 PM
Pinion John Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:20 PM
Harris Erik (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:20 PM
Kassberg Thomas Richard (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:21 PM
Parschauer Karah Herdman (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:22 PM
Bedrosian Camille L (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2020
6:23 PM
KAKKIS EMIL D (Reporting)
Ultragenyx Pharmaceutical (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:RARE) was last updated on 1/31/2023 by MarketBeat.com Staff